wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26827975-21A909FB-CB41-483B-9DBC-38235B62B370
Q26827975-21A909FB-CB41-483B-9DBC-38235B62B370
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827975-21A909FB-CB41-483B-9DBC-38235B62B370
Growth factor and signaling pathways and their relevance to prostate cancer therapeutics
P2860
Q26827975-21A909FB-CB41-483B-9DBC-38235B62B370
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827975-21A909FB-CB41-483B-9DBC-38235B62B370
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8393c84968ea08309dcb1a0ce25ea2c8d460df7e
P2860
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.